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Available online 28 June 2016Over the past decades, studies in both Huntington's disease animal models and pilot clinical trials have demon-
strated that replacement of degenerated striatum and repair of circuitries by grafting fetal striatal primordium is
feasible, safe andmay counteract disease progression. However, a better comprehension of striatal ontogenesis is
required to assess the fetal graft regenerative potential. During neuronal development, neurotrophins exert
pleiotropic actions in regulating cell fate and synaptic plasticity. In this regard, brain-derived neurotrophic factor
(BDNF) and fibroblast growth factor 2 (FGF2) are crucially implicated in the control of fate choice of striatal pro-
genitor cells. In this study, we intended to refine the functional features of human striatal precursor (HSP) cells
isolated from ganglionic eminence of 9–12 week old human fetuses, by studying with electrophysiological
methods the effect of BDNF and FGF2 on the membrane biophysical properties and the voltage-dependent
Ca2+ currents. These features are particularly relevant to evaluate neuronal cell functioning and can be consid-
ered reliable markers of the developmental phenotype of human striatal primordium. Our results have demon-
strated that BDNF and FGF2 induced membrane hyperpolarization, increased the membrane capacitance and
reduced the resting total and specific conductance values, suggesting a more efficient control of resting ionic
fluxes. Moreover, the treatment with both neurotrophins enhanced N-type Ca2+ current amplitude and reduced
L- and T-type ones. Overall, our data indicate that BDNF and FGF2may helpHSP cells to attain amore functionally
mature phenotype.





In the human brain, the corpus striatum is composed of two large
subcortical nuclear masses, the caudate nucleus and the putamen,
similar in their constituent neurons, intrinsic circuits, and neuro-
physiology. These nuclei are the main part of the basal ganglia and
work with the cortex through a complex network to co-ordinater; Cm, cell capacitance; FGF2, fi-
tance; Gm/Cm, specific conduc-
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arent reversal potential.movements, cognition and emotion, thus controlling the execution
of planned and motivated behaviors (Obeso et al., 2008). Selective
neuronal loss of the striatum, accounts for most of the clinical fea-
tures of Huntington's disease (HD), a genetic neurodegenerative
disorder characterized by cognitive, motor and psychiatric impair-
ments, which inexorably leads to death within 15–30 years (Novak
and Tabrizi, 2010). No proven medical treatments are currently
available to counteract the devastating course of the disease. Over
the past decades, studies in both HD animal models (Peschanski
et al., 1995; Armstrong et al., 2000) and pilot clinical trials
(Bachoud-Lévi et al., 2006; Reuter et al., 2008; Gallina et al., 2010;
Zuccato et al., 2010; Onorati et al., 2014; Paganini et al., 2014)
have demonstrated that replacement of degenerated striatum and
repair of circuitries by grafting fetal striatal primordium is feasible,
safe and may counteract disease progression, thus prospecting an
effective strategy to treat HD patients. The achievement of this practice
depends on the ability of the grafted cells to proliferate, differentiate,
and re-establish impaired circuitries (Tuszynski, 2007). However, sev-
eral causes may hamper graft survival, such as hypoxia, mechanical
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(Cicchetti et al., 2009; Watmuff et al., 2012). In vitro modelling is thus
necessary to help understand how primordium cells could face those
acute and chronic stressors, but several challenges remain to be faced
before using this therapy widely. Hopefully, optimization of transplan-
tation protocols and improvement of functional outcome may be
reached thanks to a better comprehension of striatal ontogenesis and
fetal tissue potential.
During neuronal development, neurotrophic factors exert pleiotro-
pic actions in regulating cell fate, synaptic plasticity, as well as circuitry
formation and maintenance (Park and Poo, 2013). In this regard, brain-
derived neurotrophic factor (BDNF) and fibroblast growth factor 2
(FGF2) have been crucially implicated in the control of proliferation
and fate choice of striatal progenitor cells (Grothe and Timmer, 2007;
Cohen-Cory et al., 2010). In previous studies, we demonstrated that
human striatal precursor (HSP) cells isolated from 9 to 12-week-old
human fetuses, possessed the machinery for long-term survival, prolif-
eration and differentiation (Sarchielli et al., 2014), even under hypoxic
conditions (Ambrosini et al., 2015). In addition, this HSP cell plasticity
was maintained in vitro by the mentioned neurotrophins BDNF and
FGF2 in a peculiar manner. Indeed, if on one hand these neurotrophins
promoted an undifferentiated state of HSP cells inducing neurogenesis,
migration and survival, on the other hand, they stimulated
neuritogenesis and thereby maturation of the main component of HSP
cell population (Sarchielli et al., 2014). Since HSP cells endogenously
produce BDNF and FGF2, these neurotrophins could also play an impor-
tant autocrine–paracrine role in determining progenitor cell biology
during early striatum development. Based on this background (for a re-
view see Zuccato et al., 2010) and on recently published research
(Onorati et al., 2014), we here intended to focus the present electro-
physiological study on the effect of BDNF and FGF2 treatment on the
passive membrane properties and the different voltage-dependent
Ca2+ currents present in neuronal cells from HSP, known to be good
marker of the cell fate. In fact, the expression of the type of Ca2+ chan-
nels depends on the stage of differentiation, on the type of neuron con-
sidered and of transcripts expressed. Ca2+ currents are usually small or
absent in mesenchymal (Benvenuti et al., 2006; Heubach et al., 2004; Li
et al., 2005) or neuronal stem cell (Moe et al., 2005) but appear in neu-
ronal precursors with a prevalent L-type current (D'Ascenzo, et al.,
2006). Therefore, the early appearance of L-type Ca2+ current has a
privileged role in the regulation of gene transcription. In contrast, N-,
P/Q- and R-type Ca2+ channels are expressed later and are primarily re-
sponsible for initiation of synaptic transmission early in development
and during maturation in most systems studied to date (Reid et al.,
2003; Catterall and Swanson, 2015). Of note, the sensitivity to growth
factors varies among the different types of Ca2+ currents and the dif-
ferent kinds of neurons: in fact, a specific growth factor can deter-
mine opposite effects such as enhancement or inhibition with
different strength, time-dependence and may dramatically differ de-
pending on how it is delivered (Ji et al., 2010). Based on this back-
ground and on recently published research (Onorati et al., 2014),
we here intended to focus the present electrophysiological study
on the effect of BDNF and FGF2 treatment on the passive membrane
properties and the different voltage-dependent Ca2+ currents pres-
ent in neuronal cells from HSP (n-HSP). To date, in fact, the effects
of these growth factors on the electrical properties of the newly
formed fetal human striatal precursors have been scarcely investi-
gated. Actually, whether neuronal progenitor cells exhibit voltage-
and ligand-gated currents, features characteristic of neurons, and
whether these currents are differentially regulated by growth condi-
tions is an important question that has already been addressed in
previous studies in different cell models (Sah et al., 1997). Conse-
quently, the present results are particularly relevant to show that
neurotrophins treatment of human striatal precursors significantly
enhances the acquisition of functional features, indicative of a ma-
ture neuronal phenotype.2. Materials and methods
2.1. Cell cultures
The primary human striatal precursor (HSP) cells were isolated and
propagated in vitro fromhuman fetal striatal primordiumof 9–12week-
old legally aborted fetuses, as described previously (Gallina et al., 2008,
2010; Sarchielli et al., 2014). The use of human fetal tissue for research
purposeswas approved by the National Ethics Committee and the Com-
mittee for investigation in Humans of the University of Florence (Proto-
col no 678304). HSP cells are a mixed population including neural stem
cells, glial- and neuronal-committed progenitors and mature neurons
with a striatal phenotype, with this latter component being highly
expressed, as previously demonstrated by an extensive characterization
(Sarchielli et al., 2014; Ambrosini et al., 2015). For electrophysiological
experiments, 105 cells were seeded onto coverslips, serum starved for
24 h and then stimulated with 50 ng/ml BDNF or 50 ng/ml FGF2 alone
or after 30min of preincubationwith 200 nMof their receptor inhibitors
k252a and PD173074, respectively. After a 24 h incubation (37 °C), the
stimulated or unstimulated cells were analyzed by electrophysiology.
In a further set of experiments, we tested the effects of both growth fac-
tors given in combination for 24 h (50 ng/ml FGF2+ 50 ng/ml BDNF).
Finally, to test a time-dependence of the response to growth factors,
we performed electrophysiological records under acute treatment and
at a later time point (48 h).
All the electrophysiological recordings were performed in selected
cells with a marked spindle-shaped neuronal morphology (n-HSP).
The statistical analysis included only selected n-HSP showing:
1) voltage-dependent L-type Ca2+ currents and a RMP more negative
than −40 mV, since cells that did not show L-type Ca2+ currents and
with RMP more positive to such a value are usually considered stem
cells (Heubach et al., 2004; Li et al., 2005; Moe et al., 2005; Benvenuti
et al., 2006; D'Ascenzo et al., 2006); 2) a membrane time constant
N10 ms, since glial-like cells, although have generally a RMP close to
−70 mV, have a time constant definitely b10 ms (Westerlund et al.,
2003) suggesting a less wide cell surface. Accordingly, the reported
data are related to the cells that satisfied these criteria, namely the
70% of the patched control cells, the 84% of BDNF- and 82% of FGF2-
treated cells.2.2. Solutions for electrophysiological experiments
Coverslips with the adherent n-HSP cells in control medium were
first superfused at a rate of 1.8mlmin−1 with a physiological bath solu-
tion having the following composition (mM): 150 NaCl, 5 KCl, 2.5 CaCl2,
1 MgCl2, 10 D-glucose and 10 HEPES (pH 7.4 with NaOH). To block the
high voltage activated Na+ channels sensitivity, we used TTX (1 μM).
Ca2+ currents were recorded in a Na+- and K+-free solution, namely
a TEA-Ca2+ bath solution, containing (mM): 10 CaCl2, 145 TEABr and
10 HEPES. For the specific blockade of L-type Ca2+ channels, Nifedipine
(Sigma) was diluted at 10−2 M in DMSO and stored at 4 °C; it was used
at 3 μM.ω-Conotoxin-GVIA (ω-CTx-GVIA) andω-agatoxin-IVA (ω-Aga-
IVA (both from Alomone Labs, Jerusalem, Israel) were diluted in dis-
tilled water at 5 × 10−4 and 10−4 M, respectively, and stored at 20 °C;
ω-CgTx-GVIA was used at 500 nM to specifically block N-type channels
and ω-Aga-IVA at 200 nM to block P and Q-type channels. Drugs were
prepared daily from stock solutions, just before use. To prevent degra-
dation during the experiments nifedipine was stored in the dark and
toxins at 4 °C. T-type currents were minimized by using a holding po-
tential (HP) of −40 mV or by using Ni2+ (200 μM); thus, T-current
was evaluated by subtracting the resulting current from the total Ca2+
currents. The recording pipettes were filled with a filling pipette solu-
tion containing (mM): 150 CsBr, 5 MgCl2, 10 EGTA and 10 HEPES
(pH 7.2 with KOH). To test the effects of dopaminergic agonists,
SKF82958 (10 μM; Sigma-Aldrich) or quinpirole (10 μM, Sigma-
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were acutely added to the bath solutions.
2.3. Electrophysiological stimulations and records
Low-resistance patch pipettes (3–7 MΩ) made from borosilicate
glass tubing (Harvard apparatus LTD) using a vertical puller (Narishige,
Tokyo, Japan) were used for whole-cell patch clamp recordings in
voltage- or current-clamp condition. The whole-cell configuration was
obtained after gentle application of negative pressure. Access resistance
was continuouslymonitored during the experiments. Only those cells in
which access resistance was stable (changes b10%) were analyzed.
Pclamp6 (Axon Instruments, Foster City, CA) software was used for
analysis. The technique, set up and electronics are as described in details
in an earlier report (Benvenuti et al., 2006). Briefly, the patch pipette
was connected to a micromanipulator and an Axopatch 200B amplifier
(Axon Instruments). Voltage-clampprotocol generation and data acqui-
sition were controlled by using an output and an input of the A/D-D/A
interfaces (Digidata 1200; Axon Instruments) and Pclamp 9 software
(Axon Instruments). Currents were low-pass filtered with a Bessel filter
at 2 kHz. The stimulation protocol for activation was applied to the cell
held at HP of −80 mV. 1-Second long test pulses ranged from −80 to
50mVandwere applied in 10mV steps. The stimulation protocol for in-
activation consisted of a voltage test step to −20 mV, preceded (pre-
pulsed) by the same voltage pulses used for activation. The acquisition
rate for activationwas 10 kHz and 5 kHz for inactivation. The interpulse
interval was 500 ms. Capacitive and leak currents were automatically
subtracted from the records by the P4 procedure.
The steady-state ionic current activation was evaluated by
Ia Vð Þ ¼ Gmax V−V revð Þ= 1þ exp Va−Vð Þ=ka½ f g ð1Þ
and steady-state inactivation by
Ih Vð Þ ¼ I= 1þ exp − Vh−Vð Þ=kh½ f g; ð2Þ
where Gmax is the maximal conductance for the Ia, Vrev is the apparent
reversal potential, Va and Vh are the potentials eliciting the half-
maximal size, ka and kh are the steepness factors.
Electrode capacitancewas compensated before disrupting the patch.
The passive properties parameters were estimated as in previous works
(Benvenuti et al., 2006; Di Franco et al., 2016) by applying two step volt-
age pulses to−80 and−60 mV starting from a HP=−70 mV. Access
resistance (Ra) was not compensated for monitoring membrane area.
Series resistance was compensated up to 70 ± 90%. The area beneath
the capacitive transient and the time constant of the transient's decay
(τ) were used to calculate the cell linear capacitance (Cm) (see also
Sartiani et al., 2007) and Ra from τ= RaCm. The measurement of mem-
brane resistance (Rm)were corrected for Ra andwas calculated from the
steady-state membrane current (Im) using the relation: Rm = (ΔV −
ImRa) / Im, where ΔV is the command voltage step amplitude. The ratio
1/Rm, that is the membrane conductance Gm was used as an index of
the resting cell permeability. Cm, was used as an index of the cell surface
area assuming that membrane-specific capacitance is constant at 1 μF/
cm2. The membrane conductance Gm was normalized to cell linear ca-
pacitance (Cm) to allow comparison between different cells. The ratio
Gm/Cm is then proposed as specific conductance.
RMP was recorded by switching to the current clamp mode of the
200 B amplifier. Experiments were performed at 22 °C.
2.4. Statistics
The statistical analysis of the results was attained by pClamp9 (Axon
Instruments). To evaluate if RMP, passive membrane properties and ICa
were significantly affected by neurotrophins respect to the control, data
were statistically analyzed by means of Student's t-test. More than twogroups were compared using ANOVA. When ANOVA indicated signifi-
cant differences, the Newman-Keuls post-test for multiple comparisons
between groups was performed. Experimental results are indicated as
mean ± SEM. P value ≤0.05 was considered significant (confidence
limits used are the 95%) unless otherwise specified. We assumed nor-
mally distributed samples.
3. Results
3.1. Effects of growth factors on n-HSP cells restingmembrane potential and
membrane passive properties
The analysis of resting membrane potential, RMP, achieved in cur-
rent clamp mode showed that n-HSP had a mean value of −59.6 ±
3.53 mV in control condition (Fig. 1A, Ctr). Acute addition of BDNF or
FGF2 (50 ng/ml) directly injected in the recording chamber caused ap-
preciable effects on the cell membrane, appearingwithin 5min of appli-
cation. Both neurotrophins caused a transientmembrane depolarization
(−47.1 ± 4.0 and 49.8 ± 5.1 mV, see respectively Fig. 1Aa, BDNF (5′)
and Fig. 1Ab, FGF2 (5′)) in respect to control values.
Then, to test the ability of the neurotrophins to facilitate the neuro-
nal differentiation, n-HSP cells were pretreated with BDNF or FGF2
(50 ng/ml) before electrophysiological analysis. In line with our previ-
ous study (Sarchielli et al., 2014), we chronically treated n-HSP cells
with BDNF or FGF2 for 24 h and this resulted in a significant membrane
hyperpolarization (−67.6± 4.52 and−71.6± 7.5mV, respectively) in
respect to control values. Still in agreement with Sarchielli et al. (2014),
we also performed experiments with neurotrophins receptor inhibi-
tors: k252a (K) for BDNF and PD173074 (P) for FGF2. The 24-h pretreat-
ment with BDNF and its receptor inhibitor K or with FGF2 and its
receptor inhibitor P, induced a statistically significant membrane depo-
larization (−37.0 ± 6.93 and −45.5 ± 4.7 mV respectively), reaching
voltages even more positive than control. However, we did not observe
statistically significant differences between BDNF and FGF2 treatment
(Fig. 1Aa and Ab, respectively). Prolonged treatment with
neurotrophins (48 h) did not cause further alterations in RMP, which
was not statistically different to control, as shown in Fig. 1Aa for BDNF
treatment.
Successively, by switching to the voltage clamp mode of our device,
we estimated the membrane passive properties. We first evaluated the
cell capacitanceCm that is considered an index of cell surface (Fig. 1B). In
a first set of experiments, BDNF or FGF2 were acutely added to the re-
cording bath solution and electrophysiological measurements were
made within 5 min from application. We observed that both BDNF
and FGF2 caused a significant increase in cell capacitance (27.1 ± 2.8
and 25.0 ± 3.5 pF), respect to control (19.4 ± 2.9 pF), suggesting a
rapid cell surface enlargement. Moreover, they induced an increase in
Gm (3.5 ± 0.3 and 4.3 ± 0.4 nS respect to control, 2.9 ± 0.3 nS), and a
decrease of specific conductance Gm/Cm (0.13 ± 0.03 and 0.17 ±
0.03 nS/pF respect to control, 0.19 ± 0.03 nS/pF) (Fig. 1C and D).
When the neurotrophinswere chronically added in culture medium
for 24 h they induced, respect to control, a statistically significant in-
crease of Cm parameter (25.5 ± 1.6 pF in BDNF and 29.51 ± 4.8 in
FGF2) suggesting a further cell surface enlargement. Once again, we ob-
served that the pretreatment with the growth factors and their specific
receptor inhibitors caused a consistent decrease in Cm (15.3 ± 1.7 and
16.0 ± 3.10 pF, respectively) respect to the growth factor alone and re-
spect to control (Fig. 1 B). Finally, themembrane conductance (Gm) that
is an index of resting cellmembrane permeability (3.7±0.21 nS in con-
trol) was significantly decreased by BDNF (2.6 ± 0.48 nS) and FGF2
treatment (2.6 ± 0.6 nS). The pretreatment with these growth factors
and their receptor inhibitors definitely increased its value respect to
control resulting 3.9 ± 0.3 and 4.4 ± 0.5 nS, respectively vs. 3.7 ±
0.21 nS (Fig. 1C). Similarly, the specific conductance (Gm/Cm) was also
modified; being 0.1± 0.01 and 0.09± 0.01 nS/pF in BDNF and FGF2 re-
spect to control (0.19 ± 0.02 nS/pF). The pretreatment with
Fig. 1. Effects of BDNF and FGF2 onn-HSP cells RMPand restingmembraneproperties. Effects of growth factors as a function of time and of thepresenceof their receptor inhibitors, onRMP
(A), Cm (B), Gm (C) and Gm/Cm (D). Ctr, untreated cells (dashed line bars) are the same in panels a and b. BDNF (white bars, panels a), FGF2 (grey bars, panels b) and FGF2+ BDNF (black
bars, panels b). Acute treatment for any growth factor is indicated in the graphs as (5′). Chronical treatments with neurotrophins are indicated as BDNF (24 h), BDNF (48 h) and FGF2
(24 h). n-HSP cells in culture for 24 h with BDNF pretreated with its receptor inhibitor k252a (BDNF + K) or with FGF2 pretreated with its receptor inhibitor PD173074 (FGF2 + P);
n-HSP cells in culture for 24 h with FGF2 and BDNF (FGF2+ BDNF). *, ** and *** indicate P b 0.05, P b 0.01 and P b 0.001 vs Ctr; +, ++ and +++ indicate P b 0.05, P b 0.01 and P b 0.001
vs 24 h treatment; §;§§ and §§§ indicate P b 0.05, P b 0.01 and P b 0.001 for BDNF or FGF2 plus their receptor inhibitor (BDNF + K and FGF2 + P) vs BDNF or FGF2 alone. Analyzed cells:
n = 42 for Ctr; n = 24 for BDNF (24 h); n = 30 for FGF2 (24 h); n = 8 for acute and for 48 h-treatment; n = 8 for FGF2+ BDNF (24 h). Data are mean ± SEM.
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0.27 ± 0.03 nS/pF, respectively (Fig. 1D).
Tofindout a possible synergistic effectwe also investigated the com-
bination of FGF2+ BDNF at the same time point. The results obtained
are depicted as black bars in Fig. 1 (panels b). The RMP resulted signifi-
cantly hyperpolarized respect to control, but not statistically different to
values obtained with FGF2 treatment alone (Fig. 1Ab). The cell capaci-
tance showed values similar to those obtained with BDNF alone
(Fig. 1Ba and Bb), whereas Gm was slightly higher than those due to in-
dividual growth factors (Fig. 1Ca and Cb). Finally, Gm/Cm values showed
a not statistically significant increase respect to individual growth fac-
tors (Fig. 1Da and Db).
Again, to determine if the neuronal response to neurotrophins
changed as function of time, the same passive properties were mea-
sured also on n-HSP cells treated for 48 h.We observed a further net in-
crease in Cm and Gm values, but the Gm/Cm values resulted not
statistically different to control. As an example,we have reported the re-
sults obtained with BDNF in Fig. 1Ba, Ca and Da.
3.2. Ca2+ current type occurring in n-HSP cells
We then investigated the voltage-dependent Ca2+ currents, known
to play a key role in neuronal functioning and neurotransmission. Ca2+
currents were first recorded in voltage clamp mode from n-HSP cells
cultured in control condition for 24 h. Cells plated on the coverslip
were placed in the recording chamber filled with the Na+- and K+-
free solution (namely a TEA-Ca2+ bath solution) to record only Ca2+
currents.
Typical Ca2+ current traces were evoked from HP of −80 mV by
depolarizing steps from −70 to 50 mV applied in 10 mV increments
(Fig. 2Aa). As a confirmation, Cd2+ (100 μM) added in the bath solution
blocked such currents (not shown, n = 7). We observed that inward
currents were activated starting from −60 mV as transient currents
(Fig. 2Ab). This low voltage of activation and the typical transient time
course suggested the occurrence of the LVA T-type Ca2+ current in
our preparation. Starting from −40 mV, this current superimposed on
a slow activating and inactivating current that reached the maximal
value with the 10 mV step, indicating also the presence of HVA current
type. The mean total Ca2+ current density was 37.1 ± 4.3 pA/pF (n =
42) (Fig. 2B, filled circles). The plots of the total current peak amplitude
vs. membrane potential show a shoulder at about−20 mV, suggesting
the presence of several components (Fig. 2B, filled circles). To investi-
gate in depth the different types of HVA Ca2+ currents involved, we
made a pharmacological dissection by sequentially applying nifedipine
(3 μM), ω-Ctx-GVIA (500 nM), and ω-Aga-IVA (200 nM) on the same
n-HPS cell, to block L-, N-, and P/Q-type channels, respectively. Typical
current traces elicited by a depolarizing pulse to 10 mV in control and
after the adding of the Ca2+ channels blockers are depicted as an exam-
ple in Fig. 2C. At this pulse potential in fact, all HVA currents types (L, N,
P/Q and R) are aboutmaximally activated and can be better discriminat-
ed by the use of specific blockers. The residual current observed in pres-
ence of the three specific blockers mentioned above was the result of
LVA T-type plus the R-type Ca2+ currents. The single R-type Ca2+-
current component was estimated by blocking the T-type one by Ni2+
(Fig. 2Cb). Finally, the presence of T-type currents was confirmed after
subtracting the traces recorded in the presence of Ni2+ (Fig. 2Cb), or
evoked at HP = −40 mV, from the total Ca2+ currents. The complete
representative families of the current traces obtained after pharmaco-
logical dissection are shown in Fig. 3. The 80% of the analyzed cells
showed all the types of Ca2+ currents, whereas the 10% did not show
the P/Q-type and in another 10% both the P/Q- and R-types were absent
or hardly discernable from noise.
HVA Ca2+ currents were further characterized by studying their ac-
tivation kinetics, measured as the maximal current elicited by the 10-
mV step. The N-, R- and P/Q-type currents activatedwith time constants
of 8.0 ± 0.6, 9.6 ± 0.8 and 6.5 ± 0.6 ms for N-, R- and P/Q-type,respectively. The L-type Ca2+ currents activated with a slower kinetics,
having a time constant of 21.9 ± 0.2 ms. With regard to inactivation
phase, the R-type Ca2+ currents could be fitted by an exponential func-
tion having a rather fast time constant of 80 ± 7ms; in contrast, L-type
currents inactivate following two rather slow exponentials (τ1 =
360± 45 and τ2 = 750 ± 82ms), whereas P/Q and N type currents in-
activate very slowly (about 1080–1100 ms). Finally, the LVA fast tran-
sient T-type currents elicited at −30 mV, activate and inactivate with
time constant of 2.0 ± 0.2 and 4.5 ± 0.4 ms, respectively.
The I/V plots related to each single component isolated by pharma-
cological means are depicted in Fig. 4. The LVA T-type maximal current
was elicited by the −20 mV-voltage pulse (Table 1). In contrast, the
maximal peak amplitude of all the HVA currents was obtained with
the 10-mV step, but each component showed different voltage thresh-
olds of activation: P/Q- and R-type currents activated at about
−30 mV whereas L- and N-types had a lower threshold of activation,
being−50 and −40 mV, respectively (Fig. 4).
The I/V relationship of all the Ca2+ current types can be fitted by a
single Boltzmann function, with half-maximal activation potentials
around −5 mV for N-, P/Q and R-type and −2.0 ± 0.6 for L-type (see
Tables 2–3). The HVA Ca2+ current typewith the lowest voltage thresh-
old of activationwas the L-type, butVa and the voltage eliciting themax-
imal Ca2+ current (Vp) were shifted to more positive potential
(Tables 2–3). This nifedipine-sensitive L-type Ca2+ current was the
main current type observed in these cells, with amaximalmean density
of 24.1 ± 2.4 pA/pF. The other Ca2+ current types showed a mean den-
sity forω-CgTx-GVIA-sensitive N-type Ca2+current of 11.3±1.1 pA/pF,
for R-type of 5.5±0.8 pA/pF, forω-Aga-IVA-sensitive P/Q-type currents
of 1.3 ± 0.5 pA/pF and for T-type 4.9 ± 0.7 pA/pF (Fig. 5A, Ctr).
3.3. Effects of growth factors on Ca2+ currents
The aim of the present study was to determine whether BDNF,
known to regulate neuronal cell migration, and FGF2, could modulate
voltage-dependent calcium currents in HSP cells. Accordingly, themea-
surements described above were repeated using n-HSP cells treated
with BDNF (n = 24) or FGF2 (n = 30) for 24 h. Both BDNF and FGF2
treatment caused a reduction of the total Ca2+ current amplitude
(Fig. 2B). In contrast, the treatment in the presence of their specific re-
ceptor inhibitor (BDNF + K and FGF2 + P) gave results similar to
those obtained in control condition (Fig. 2B). However, to evaluate
whether these neurotrophins had effect on a definite type of Ca2+ cur-
rent, we applied the same procedure described above for analyzing L-,
N-, P/Q, R- and T-type Ca2+ currents separately. Our results showed
that the kinetics (Va and ka Boltzmann parameters) of such channels
was not significantly affected. Nonetheless, L- and T-type current specif-
ic maximal size (ICa,max/Cm) and conductance (Gm/Cm) were reduced by
a similar amount (about the 50%) both by BDNF and FGF2 (Figs. 4 and 5;
Tables 1 and 2).
In contrast, ICa,max/Cm and Gm/Cm of N-type Ca2+ currents were en-
hanced, but FGF2 caused a stronger effect than BDNF. Finally, these
treatments did not significantly affect the Boltzmann parameters of P/
Q and R type Ca2+ currents (Figs. 4 and 5; Table 3). The combination
of both neurotrophins together at the same time point, did not give sig-
nificant differences respect to individual growth factors (data not
shown).
For completeness, also in this case n-HSP cells were cultured in the
presence of the neurotrophins and their related receptor inhibitor for
24 h. In this condition, the specific maximal current size and conduc-
tance were reverted to values not statistically different respect to con-
trol (Figs. 4 and 5; Tables 1–3).
To test if this neuronal response to neurotrophins varied as function
of time, we made further experiments at different time points (see
Fig. 5).
Acute treatment caused in both cases a reduction of L-type Ca2+ cur-
rent that was more evident under BDNF. N-type Ca2+ current resulted
Fig. 2. Voltage-dependent Ca2+ current and pharmacological dissection of the different components in n-HSP cells. Aa) Typical family of total Ca2+ current traces elicited from
HP = −80 mV in control condition; voltage steps ranging −70 to 50 mV in 10-mV increments. Ab) Same traces as in Aa, showed with a different ordinate scale to better observe the
occurrence of LVA and HVA Ca2+ currents. B) Current vs voltage relationship (I/V plots) of the maximum specific total Ca2+ currents in control (filled circles) and after the treatment
with BDNF or FGF2 (24 h) alone (filled triangles and squares, respectively) and together with their specific receptor inhibitor BDNF + K or FGF2 + P (open triangles and squares,
respectively). Data are the mean values of n = 42 (Ctr), 24 (BDNF), 30 (FGF2), 16 (BDNF + K) and 14 (FGF2 + P) different cells. Ca) Pharmacological dissection of different Ca2+
currents: for clarity, only a typical Ca2+ current trace evoked by the voltage pulse at 10 mV (HP = −80 mV) is depicted for any treatment. Control condition (a trace: Ctr) and after
the application of the specific L-type Ca2+ channel blocker nifedipine (3 μM) (b trace: Ctr + Nif). In sequence, ω-conotoxin-GVIA (v-CgTx-GVIA) (500 nM) was added to block N-type
current (c trace) and ω-agatoxin-IVA (v-Aga-IVA) (200 nM) to block P/Q-type current (d trace); the residual current is the transient T- type Ca2+ current superimposed on R-type
Ca2+ current (d trace). Cb) Typical single Ca2+ current-components obtained by subtracting trace b from a (L-type current = a–b), c from b (N type current = b–c) and d from c (P/Q
type current = c–d). R-type component is obtained after application of Ni2+ (200 μM) to block T-type Ca2+ current; T-type Ca2+ current was obtained by subtracting R-type Ca2+
current trace depicted in Ca from R trace in Cb.
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low-voltage activated components were not significantly altered by
the neurotrophins directly added to the bath solution.
In order to add a later time point to our analysis, we recorded the
effect on Ca2+ currents from n-HSP cells treated for 48 h. We found
that T- and L-type Ca2+ currents were not significantly altered re-
spect to 24 h, whereas the N-type was the only one further increased
by this longer treatment. Again, no other HVA currents were affect-
ed by the growth factors respect to control. Results obtained with
BDNF for each type of Ca2+ current, are depicted as histograms in
Fig. 5.
3.4. Effects of dopaminergic agonists on n-HSP cells
To test another important indicator of the differentiation state, we
also aimed to investigate the effect of dopaminergic agonists onmembrane properties and Ca2+ currents. Since a previous study of our
research group (Sarchielli et al., 2014) showed that our n-HSP cells
expressed D1 and D2 receptors mRNA, we tested the effect of
SKF82958 or quinpirole selective for D1- and D2-dopamine receptors,
acutely applied to the bath solution.
We consistently found that each dopaminergic agonist induced a
slight membrane hyperpolarization of 3.1 ± 0.2 for quinpirole and
2.3 ± 0.2 mV for SKF82958. An example of representative tracings elic-
ited in current clamp during application of the quinpirole and SKF is re-
ported in Fig. 6A and B. Both dopaminergic agonists affected the
membrane passive properties: they induced a decrease of cell capaci-
tance that wasmore evident for SKF. In contrast, the resting and specific
conductance were definitely enhanced, especially by quinpirole, but re-
duced by SKF respect to control (Fig. 6D–F).
We also tested the ability of dopaminergic agonists to modulate the
calcium channel function in n-HSP cells. We could clearly observe that
Fig. 3. Time course of different types of Ca2+ current in a single n-HSP cell. Typical families of current traces evoked in control conditions; voltage steps ranged from−70 to 50mV in 10-
mV increments (HP = −80 mV). A–E) Each family of traces related to a single component is obtained by the mathematical subtraction according to the method as in Fig. 2.
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rent amplitude without altering the R-, P/Q- and T-type (Fig. 6G).
4. Discussion
In the present study, we examined human neuronal cells from
striatal precursors isolated from human fetuses obtained as described
in detail in Sarchielli et al. (2014). As showed by the Authors, HSP
cells expressed D1 and D2 receptors mRNA, and since the expression
of dopamine receptors is a good indicator of differentiation state, we
tested the effects of dopaminergic agonists on membrane properties
and their ability to modulate Ca2+ currents. Although from a functional
point of view our cells are quite immature precursors, as suggested bythe absence of action potentials firing, n-HSP were already capable to
respond to D1 and D2 agonists. In fact, the treatmentwith their agonists
hyperpolarized the resting membrane potential, changed the passive
membrane properties and decreased L-, N- and P/Q-type Ca2+ current
amplitude.
Moreover, as recently published by Sarchielli et al. (2014), our cells
express neurotrophins, such as FGF2 and BDNF, along with the cognate
receptors FGFR1 and TrkB, respectively. Particularly, FGF2 can be accu-
mulated in extracellular matrix and may be internalized (Presta et al.,
2005), whereas BDNF binds to TrkB (Reichardt, 2006; Zhang et al.,
2012). This regulates the expression and activity of functionally impor-
tant proteins such as ion channels and neurotransmitter receptors, and
consequently regulates synaptic strength and plasticity (Vicario-Abejón
Fig. 4. Effects of BDNF or FGF2 treatment, alone and in the presence of their receptor inhibitors, on the different types of Ca2+ currents evoked in n-HSP cells. A–E) Current vs voltage
relationship (I/V plots) of the single Ca2+-current types from experiments as in Fig. 3, in the different culture conditions: in control (filled circles) and after the 24-h treatment with
BDNF or FGF2 alone (filled squares and triangles, respectively) and together with their specific receptor inhibitor BDNF + K or FGF2 + P (open triangles and squares, respectively).
The best fit to the experimental data points for any Ca2+ current type is obtained by a single Boltzmann function. Boltzmann parameters are listed in Tables 1–3. Data are the mean
values of n = 42 (Ctr), 24 (BDNF), 30 (FGF2), 16 (BDNF + K) and 14 (FGF2 + P) different cells.
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neurotrophins have shown the ability to induce migration, survival and
neuritogenesis of HSP cells (Sarchielli et al., 2014) and stronger modifi-
cations of the membrane properties (present study), thus suggesting a
maturation of the main component of HSP cell population towards a
more typical neuronal phenotype.
After having elucidated the biophysical properties of our cells, in this
research we mainly focused on Ca2+ currents modulation by the
neurotrophins, since Ca2+ channels are considered good markers of
the cell fate and neuronal differentiation. In fact, the Ca2+ ions entry is
known to control a variety of crucial functions in neurons, including
the cell excitability, the neurotransmitter release, somato-dendritic ret-
rograde release and other intracellular events. Ca2+ ions can enter the
cell through a variety of channels and between these, the voltage-
operated Ca2+ channels are typically grouped into a number of classes
based on their voltage-dependence and pharmacological properties. Ac-
cordingly, different types of Ca2+ currents can be described in neurons:
the low-voltage-activated (LVA) T-type currents and the high voltage-
activated (HVA) currents; these latter can be distinguished into L-, N-,P/Q- and R-type. These voltage-operated Ca2+ channels are crucial for
different biological events and are regulated by various signalling path-
ways, which has profound functional consequences (Wu et al., 2002).
Notably, the expression of the type of Ca2+ channels depends on the
stage of differentiation of the type of neuron considered and of the tran-
scripts expressed. Accordingly, the kind of Ca2+ current detected is a
good indicator of the cell fate. In fact, Ca2+ currents are very small in
amplitude or completely absent in neuronal stem cells (Moe et al.,
2005). In contrast, they appear in neuronal precursors with a prevalent
L-type Ca2+ current (D'Ascenzo et al., 2006).
It is well known that in neurons, Ca2+ influx via presynaptic Ca2+
channels is an obligatory step for neurotransmission that gives rise to
a complex cascade of events in the synaptic junction. However, the pre-
synaptic terminals do not necessarily express the same combination of
Ca2+ channel types, even when terminals emanate from the same
axon. The different types of Ca2+-channels are located in different cell
sites (Hell et al., 1993;Westenbroek et al., 1990) and are prevalently in-
volved in different functions (Joux et al., 2001; Reid et al., 2003; Catterall
and Goswami et al., 2012). For example, the L-type and T-type Ca2+
Table 1
Boltzmannparameters of T-type ICa activation curve in n-HSP cells cultured for 24 h in control solution (Ctr), in the presence of BDNF or FGF2 alone orwith their specific inhibitor added (K
and P, respectively).
Parameters Ctr BDNF FGF2 BDNF + K FGF2 + P
ICa,T
ICa,max/Cm (pA/pF) 4.9 ± 0.6 2.0 ± 0.4⁎⁎ 2.5 ± 0.3⁎⁎,§ 4.8 ± 0.8 3.9 ± 0.8
Gm/Cm (pS/pF) 47.1 ± 4 18.9 ± 3⁎⁎ 23.6 ± 4⁎⁎,§ 46.2 ± 5 37.3 ± 5
Vp (mV) −25.2 ± 2 −26.5 ± 2 −25.9 ± 2 −25.4 ± 3 −25.3 ± 3
Va (mV) −40.0 ± 4 −41.2 ± 2 −41.6 ± 1 −40.6 ± 1 −40.9 ± 2
ka (mV) 6.5 ± 0.4 6.3 ± 0.5 6.7 ± 0.4 6.6 ± 0.6 6.6 ± 0.5
Vrev (mV) 86.0 ± 7 88.4 ± 9 88.3 ± 8 87.3 ± 8 86.2 ± 9
Both neurotrophins increase themaximumpeakof the specific current size, ICa,max/Cm, and the relatedmaximalGm/Cm. Data aremean±S.E.M. Data fromCtr:n=42; BDNF n=24, FGF2 n
= 30; BDNF + K n = 16 and FGF2 + P n = 14.
⁎⁎ P b 0.01 treated cells vs control.
§ P b 0.05 FGF2 vs BDNF.
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the N-type channels might be selectively expressed at recently formed
terminals, or in a ‘reserve’ pool of terminals held in an immature state,
whereas P/Q-type channels might dominate at fully mature and active
terminals (Momiyama, 2003).
Since the aim of this research was to evaluate the effect of two
neurotrophins on our cell model, it must be considered that any growth
factormay selectively affect thedifferent types of Ca2+ channels and the
sensitivity may vary among the different kinds of neurons (Yang and
Tsien, 1993; Colston et al., 1998; Bouron et al., 2006). Moreover, the
final effects may depend on how neurotrophins are delivered (Ji et al.,
2010). Thus, the temporal aspect in cell signalling may also have impli-
cations for the therapeutic drug design and since our cells express TrkB
(Sarchielli et al., 2014) this feature can be relevant also in the present
study. In fact, experiments achieved with acute application of BDNF
showed different effects on passive properties and differentmodulation
of Ca2+ currents respect to chronical treatment. This can be considered
in good in agreement with Ji et al. (2010), that observed that the two
modes of BDNF delivery also caused very different morphological
changes in cultured hippocampal neurons and further supports a critical
role of the kinetic of TrkB activation for cell signalling and functions.
It is known that the activity of voltage-operated ion channels can be
finely regulated by neurotransmitters, growth/trophic factors and hor-
mones (Bean, 1989; Boland and Bean, 1993; Wu et al., 2002). In the
present study, we found that n-HSP cells cultured in control condition
showed all the LVA and HVA Ca2+ current types. Among these, the L-
type was the prevalent one whereas N-, R-, T- and P/Q types showed a
progressivelyminor amplitude. Notably, we observed that the chronical
treatment with BDNF and FGF2 neurotrophins definitely affected the
voltage-dependent Ca2+ current occurrence, likely ascribable to aTable 2




ICa,max/Cm (pA/pF) 24.0 ± 2 10.1 ± 1⁎⁎
Gm/Cm (pS/pF) 368.6 ± 23 131.5 ± 11⁎⁎
Vp (mV) 15.2 ± 2 15.5 ± 2
Va (mV) −2.0 ± 0.6 −2.2 ± 0.5
ka (mV) 8.0 ± 0.4 7 ± 0.6
ICa,N
ICa,max/Cm (pA/pF) 11.3 ± 0.8 15.8 ± 1⁎⁎
Gm/Cm (pS/pF) 162.0 ± 19 226.8 ± 20⁎⁎
Vp (mV) 10.2 ± 1 10.5 ± 2
Va (mV) −4.5 ± 0.4 −4.2 ± 0.4
ka (mV) 6.5 ± 0.4 6.3 ± 0.5
Vrev (mV) 84.0 ± 7 85.8 ± 9
Neurotrophins reduce the maximum peak current size, ICa,max/Cm and the related maximal Gm/
cells as in Table 1.
⁎⁎ P b 0.01 treated cells vs control
§ P b 0.05 FGF2 vs BDNF.sustained TrkB activation. In fact, both BDNF and FGF2 reduced T- and
L-type specific current-amplitude and conductance, while enhanced
that of N-type Ca2+ channels. In contrast, P/Q- and R-type Ca2+ current
were not appreciably affected by the treatments. Parallel changes of the
maximal amplitude and conductance were determined by the
neurotrophins with no effects on Va or ka Boltzmann parameters.
Hence, we suggest that chronical treatment with FGF2 and BDNF does
not substantially affect the ion channels kinetics but can be effective in
changing the functional expression of different Ca2+ channels on the
plasmamembrane, in agreementwith the idea that sustained activation
of neurotrophin receptor and signal transduction events may alter gene
expression (Ji et al., 2010). However, we observed that these two
growth factors induced somehow different effects, since BDNF caused
a more marked reduction of L- and T-type Ca2+ currents than FGF2
did. A similar outcome has already been described for BDNF in embry-
onic cortical neurons of the mouse, where BDNF was shown to down-
regulate Ca2+ currents, acting as potent modulator of the electrical
properties of early post-mitotic neurons, thus exerting a neuroprotec-
tive action (Bouron et al., 2006). In contrast, we found that FGF2 was
more effective in enhancing N-type current respect to BDNF, suggesting
a major efficiency of FGF2 in promoting the acquisition of the channels
mostly involved in the neuronal excitatory transmitter release.
In this regard, it is to note that FGF2 is an important promoter of pro-
liferation in neuronal progenitor cells, but in neural crest cells for in-
stance, FGF2 treatment alone does not lead to cell expansion, rather
requiring the presence of a neurotrophin such as BDNF, nerve growth
factor or neurotrophin-3 (Sieber-Blum, 1998). As well, in neural stem
cells of the rat, the combination of growth factors has been reported
to have an additive effect on neural differentiation (Choi et al., 2008).
However, no synergistic morphoregulatory effects of neurotrophins orcontrol solution (Ctr), in the presence of BDNF or FGF2 alone orwith their specific K and P
FGF2 BDNF + K FGF2 + P
9.7 ± 0.8⁎⁎ 13.2 ± 2 21.6 ± 3
123.6 ± 12⁎⁎ 249.8 ± 29 236.6 ± 30
15.9 ± 2 15.4 ± 2 15.3 ± 2
−2.4 ± 0.6 −1.8 ± 0.8 −1.9 ± 0.9
7.7 ± 0.5 7.9 ± 0.6 7.8 ± 0.6
18.1 ± 0.9⁎⁎,§ 12.4 ± 1 13.6 ± 1
259.2 ± 22⁎⁎,§ 178.2 ± 18 194.4 ± 21
11.1 ± 2 10.8 ± 2 10.3 ± 2
−4.1 ± 0.5 −4.6 ± 1 −4.9 ± 1
6.2 ± 0.4 6.6 ± 0.6 6.7 ± 0.5
84.1 ± 8 86.1 ± 9 86.6 ± 9
Cm of L-type channels; in contrast, they increase those of N-type Ca2+ current. Number of
Table 3
Boltzmannparameters of P/Q- and R-type Ca2+ activation curve inn-HSP cells cultured for
24h in control solution (Ctr), in thepresence of BDNF or FGF2 alone orwith their specific K
and P inhibitor added.




1.3 ± 0.2 1.4 ± 0.3 1.4 ± 0.4 1.4 ± 0.4 1.3 ± 0.4
Gm/Cm
(pS/pF)
19.7 ± 2 21.4 ± 2 20.5 ± 2 19.8 ± 2 19.6 ± 3
Vp (mV) 10.3 ± 1 10.1 ± 2 9.9 ± 2 10.4 ± 2 10.3 ± 2
Va (mV) −5.8 ± 0.6 −5.9 ± 0.5 −6.2 ± 0.6 −5.7 ± 0.8 −5.8 ± 0.9
ka (mV) 6.7 ± 0.4 6.3 ± 0.5 6.7 ± 0.4 6.5 ± 0.6 6.7 ± 0.6




5.5 ± 0.6 5.6 ± 1 5.5 ± 0.8 6.2 ± 1 5.3 ± 3
Gm/Cm
(pS/pF)
63.6 ± 6 64.5 ± 6 65.6 ± 5 64.1 ± 29 63.6 ± 30
Vp (mV) 10.2 ± 2 12.5 ± 2 9.9 ± 2 11.4 ± 2 10.3 ± 2
Va (mV) −7.1 ± 0.6 −7.2 ± 0.5 −6.6 ± 0.6 6.8 ± 0.8 6.9 ± 0.9
ka (mV) 6.9 ± 0.4 6.3 ± 0.5 6.7 ± 0.4 6.7 ± 0.6 6.8 ± 0.6
Vrev (mV) 88.0 ± 7 88.8 ± 9 88.2 ± 8 88.1 ± 9 89.2 ± 10
Boltzmann parameters of cells cultured with growth factors with or without the related
receptor inhibitor are similar to the control. Number of cells as in Table 1.
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rat (Patel and McNamara, 1995). Accordingly, when we treated n-HSP
cells with the combination of BDNF and FGF2 we did not actually ob-
serve a clear synergistic effect, since only the membrane conductance
values resulted slightly higher than those due to individual growthFig. 5. Effect of BDNF and FGF2 as a function of time on L-,N-, R-, P/Q- and T-type Ca2+ currents.
time. Different times of exposure are displayed in the legends next to each panel. Peak current
−20mV for T-type current. *, ** and *** indicate P b 0.05, P b 0.01 and P b 0.001 vs Ctr; + and ++
the same current under BDNF. Data are from the same cells of Fig. 4. Values are mean ± SEM.factors. No significant alterations were observed in Ca2+-currents ex-
pression/functionality. Since growth factors are supposed to act in con-
cert in different cell lineages and in several aspects of neural crest cell
development, including survival, proliferation, and differentiation, the
underlying mechanisms that involve growth-factor-induced depen-
dence of the cells on other factors definitely deserves further investiga-
tion in a dedicated study.
Therefore, by an electrophysiological point of view, BDNF and FGF2
have clear effects on n-HSP cells. Since T-type calcium channel family
(CaVT) is present throughout the striatum as well as in the accumbens
nucleus (Talley et al., 1999), the T-type Ca2+ current may represent a
potential pacemaker current of this region of the central nervous system
(Moody and Bosma, 2005) and thus may play a role in spontaneous fir-
ing activity. Accordingly, any reduction of this kind of current can re-
duce eventual pacemaker activity of HSP cells, with functional
consequences in vivo. Moreover, theHVACa2+channels that are charac-
terized by a relatively slow activation and incomplete inactivation can
be activated by the LVA transient T-type Ca2+ current. This in turn can
activate N-, R- and P/Q-types, with their higher voltage threshold and
fast activation kinetics, possibly suggesting a greater contribution of
early Ca2+ entry during neuronal activity. It should also be remarkable
to determine in depth the relative involvement of these different cur-
rent types to Ca2+ ions entry during electrical activity of n-HSP cells,
as well as to identify the various Ca2+-dependent processes triggered
by the activation of each specific channel. Particularly, in this study,
the BDNF and FGF2 induced the enhancement of N-type Ca2+ current
and this may strongly suggest that HSP cells have attained a physiolog-
ically more differentiated phenotype. In fact, in neurons, the activation
of the voltage-gated N-type Ca2+ channel plays a significant role inThe effects of BDNF (A) and FGF2 (B) on L-, N- and T-typemaximal peak currents varywith
evoked by the voltage pulse at 10 mV (HP =−80 mV) for L-, N-, R- and P/Q-type and at
+ indicate P b 0.05 and P b 0.001 vs 24 h treatment; § and §§ indicate P b 0.05 and P b 0.01 vs
Peak currents are normalized for cell capacitance and reported in pA/pF.
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regulation of gene expression, the dendritic development and synaptic
plasticity (Toselli et al., 2005).
To further support this clue, we observed that both neurotrophins
affected also the resting membrane properties, suggesting the growth
of the surface area, the RMPhyperpolarization, the reduction of the rest-
ing total and specific membrane conductance, that is usually observed
upon differentiation (Moe et al., 2005). The decrease in membrane con-
ductance might have been caused by the decrease of membrane leak
non-specific current and/or to a lower expression of additional ionic
channels (Picken Bahrey and Moody, 2003). Therefore, this last finding
may indicate the achievement of an improved control of depolarizing
ionic influx such as leakage and/or voltage independent currents and
this may have relevance in vivo in assessing the correct excitability.
These results are in good agreement with our previous demonstra-
tion that both neurotrophins stimulate neuritogenesis in HSP cells
(Sarchielli et al., 2014). In addition, we point out a pronounced effect
of external addition of BDNF and FGF2 on voltage-activated Ca2+ cur-
rents that typically occur in untreated HSP cells. Particularly, FGF2 is
known to bind to surface membrane receptors, can be accumulated in
extracellular matrix and may be internalized (Presta et al., 2005).
Thus, the treatmentwith FGF2 andBDNF in the presence of their specific
receptor inhibitors can blunt not only the action of the growth factors
externally added to the bath solution, but also the effect of those growth
factors present on the membrane surface and internalized inside the
cells. Accordingly, we observed that the effect due to the growth factor
inhibitors was greater than expected, thus further supporting the hy-
pothesis about the role of an endogenous production of both BDNF
and FGF2 by HSP cells, as previously suggested (Sarchielli et al., 2014).
5. Conclusions
In conclusion, the treatment with BDNF and FGF2 is able to induce
specific modifications in the biophysical membrane properties of n-
HSP cells and differentlymodulate the various Ca2+ currents suggesting
that these neurotrophins are important factors in promotingHSP neuro-
nal cell maturation. Moreover, the hypothesized endogenous produc-
tion of both factors by HSP cells could be important for the
regenerative potential of fetal striatal grafts inHDpatients. However, fu-
ture studies addressing the effects of FGF2 and BDNF on electrophysio-
logical properties not only in wild type but also in HD neurons could be
of help to assess the therapeutic value of these growth factors or
advance our understanding of the degenerative nature of HD.
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